Company Filing History:
Years Active: 2013-2014
Title: Innovations by Rajesh Jayachandran in Autoimmune and Mycobacterial Treatments
Introduction
Rajesh Jayachandran is an accomplished inventor based in Basel, Switzerland. He has made significant contributions to the field of medical research, particularly in the treatment of autoimmune disorders and mycobacterial infections. With a total of two patents to his name, his work is paving the way for innovative therapeutic approaches.
Latest Patents
Rajesh's latest patents focus on coronin 1 modulators for the treatment of autoimmune and lymphoproliferative disorders, as well as mycobacterial infections. These inventions relate to the use of coronin 1 and its modulators to treat various conditions, including autoimmune disorders and the induction of immunosuppression following transplantation. The modulators are designed to inhibit the production of coronin 1 or its activation, thereby affecting T cell activation and signaling pathways. Examples of these modulators include antibody fragments, coronin 1 peptide fragments, and anti-sense oligonucleotides such as siRNA or shRNA. Additionally, the patents describe methods for screening compounds that can effectively treat these disorders by interacting with coronin 1 or its expressing cells.
Career Highlights
Rajesh Jayachandran is affiliated with the University of Basel, where he conducts his research and develops his innovative ideas. His work has garnered attention in the scientific community, contributing to